These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14692891)

  • 21. Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy.
    Grotta JC; Chiu D; Lu M; Patel S; Levine SR; Tilley BC; Brott TG; Haley EC; Lyden PD; Kothari R; Frankel M; Lewandowski CA; Libman R; Kwiatkowski T; Broderick JP; Marler JR; Corrigan J; Huff S; Mitsias P; Talati S; Tanne D
    Stroke; 1999 Aug; 30(8):1528-33. PubMed ID: 10436095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intravenous thrombolysis patients with acute ischemic stroke--the analysis of the 100 cases. Part II. Neuroimaging, the analysis of hemorrhagic complications and deaths].
    Sobolewski P; Sledzińska M; Szczuchniak W; Grzesik M; Sobota A; Hatalska-Zerebiec R
    Przegl Lek; 2012; 69(6):242-6. PubMed ID: 23094436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. NINDS; The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
    Stroke; 2000 Dec; 31(12):2912-9. PubMed ID: 11108748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimized Flat-Detector CT in Stroke Imaging: Ready for First-Line Use?
    Eckert M; Gölitz P; Lücking H; Struffert T; Knossalla F; Doerfler A
    Cerebrovasc Dis; 2017; 43(1-2):9-16. PubMed ID: 27750252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topographic Assessment of Acute Ischemic Changes for Prognostication of Anterior Circulation Stroke.
    Payabvash S; Noorbaloochi S; Qureshi AI
    J Neuroimaging; 2017 Mar; 27(2):227-231. PubMed ID: 27593522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey.
    Tanne D; Kasner SE; Demchuk AM; Koren-Morag N; Hanson S; Grond M; Levine SR
    Circulation; 2002 Apr; 105(14):1679-85. PubMed ID: 11940547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The quest for early predictors of stroke evolution: can TCD be a guiding light?
    Baracchini C; Manara R; Ermani M; Meneghetti G
    Stroke; 2000 Dec; 31(12):2942-7. PubMed ID: 11108753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Internal cerebral vein asymmetry on follow-up brain computed tomography after intravenous thrombolysis in acute anterior circulation ischemic stroke is associated with poor outcome.
    Sharma VK; Yeo LL; Teoh HL; Shen L; Chan BP; Seet RC; Ahmad A; Chong VF; Paliwal PR
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):e39-45. PubMed ID: 24119628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypodensity of >1/3 middle cerebral artery territory versus Alberta Stroke Programme Early CT Score (ASPECTS): comparison of two methods of quantitative evaluation of early CT changes in hyperacute ischemic stroke in the community setting.
    Mak HK; Yau KK; Khong PL; Ching AS; Cheng PW; Au-Yeung PK; Pang PK; Wong KC; Chan BP;
    Stroke; 2003 May; 34(5):1194-6. PubMed ID: 12690213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computed tomography findings in the first few hours of ischemic stroke: implications for the clinician.
    Fiorelli M; Toni D; Bastianello S; Sacchetti ML; Sette G; Falcou A; Argentino C; Lorenzano S; Di Angelantonio E; Bozzao L
    J Neurol Sci; 2000 Feb; 173(1):10-7. PubMed ID: 10675574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Middle Cerebral Artery Residual Contrast Stagnation on Noncontrast CT Scan Following Endovascular Treatment in Acute Ischemic Stroke Patients.
    Payabvash S; Qureshi MH; Taleb S; Pawar S; Qureshi AI
    J Neuroimaging; 2015; 25(6):946-51. PubMed ID: 25684437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.
    Albers GW; Bates VE; Clark WM; Bell R; Verro P; Hamilton SA
    JAMA; 2000 Mar; 283(9):1145-50. PubMed ID: 10703776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group.
    Stroke; 1997 Nov; 28(11):2109-18. PubMed ID: 9368550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of triphasic perfusion computed tomography for intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Lee KH; Lee SJ; Cho SJ; Na DG; Byun HS; Kim YB; Song HJ; Jin IS; Chung CS
    Arch Neurol; 2000 Jul; 57(7):1000-8. PubMed ID: 10891982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computed tomographic findings in patients undergoing intra-arterial thrombolysis for acute ischemic stroke due to middle cerebral artery occlusion: results from the PROACT II trial.
    Roberts HC; Dillon WP; Furlan AJ; Wechsler LR; Rowley HA; Fischbein NJ; Higashida RT; Kase C; Schulz GA; Lu Y; Firszt CM
    Stroke; 2002 Jun; 33(6):1557-65. PubMed ID: 12052991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noncontrast CT assessment of early cerebral ischaemia.
    Diotallevi P; Mazzetti Di Pietralata G; Montella F
    Radiol Med; 2002; 103(1-2):84-90. PubMed ID: 11859304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
    Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials.
    Martí-Fàbregas J; Bravo Y; Cocho D; Martí-Vilalta JL; Díaz-Manera J; San Román L; Puig M; Blanco M; Castellanos M; Millán M; Roquer J; Obach V; Maestre J
    Cerebrovasc Dis; 2007; 23(2-3):85-90. PubMed ID: 17114877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperdense middle cerebral artery sign as the only radiological manifestation of hyperacute ischemic stroke in computed tomography.
    Chrzan R; Gleń A; Urbanik A
    Neurol Neurochir Pol; 2017; 51(1):33-37. PubMed ID: 28341040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.